PubMed

Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future.

PMID: 41493254 · 2026-01-01

R, a, c, h, e, l, , L, , Z, i, e, b, a, r, t, ;, , B, a, r, b, a, r, a, , H, e, r, n, a, n, d, e, z, -, R, o, v, i, r, a, ;, , H, e, m, a, , S, u, n, d, a, r, a, m, ;, , S, a, m, a, n, t, h, a, , G, u, h, a, n, ;, , S, a, r, a, n, y, a, , P, , W, y, l, e, s

学術誌Journal of drugs in dermatology : JDD

年2026-01-01

PMID41493254

抄録

Regenerative dermatology is an emerging subspecialty that seeks to restore the structure and function of healthy skin. The United States lacks comprehensive regulatory guidance for regenerative therapies. This review provides an overview of available therapies within regenerative dermatology, outlining the pathways for approval. Articles on regenerative dermatology in PubMed and guidelines issued by the United States Food and Drug Administration (FDA) were reviewed with emphasis on those publish

公式ソース

PubMedで見る →

データはPubMed / NCBIから取得しています。全文および最新情報は必ず公式記録をご確認ください。